
Boostimmune is
a biotech company developing innovative, first-in-class antibody-based therapies to address unmet needs
in oncology via modulating immune systems.
Leadership
Co-founded by a world-renowned immunologist
Strong management team with extensive experience in early-stage drug development
Science
R&D focus on the development of biotherapeutics modulating immune cells and utilizing human immune systems to treat cancers